Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface. 1989

G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
Department of Molecular Biology, Latvian Academy of Sciences, Riga, USSR.

Insertion of foreign oligopeptide sequences (40-50 amino acids in length) into the Pro144 position of hepatitis B core antigen (HBcAg) leads to the formation of chimeric capsids in Escherichia coli cells. These capsids are morphologically and immunologically similar to native HBcAg, but expose the inserted oligopeptides on their outer surface and exhibit antigenic and immunogenic characteristics of the latter. As a source of model antigenic determinants, the appropriate DNA copies excised from cloned viral genes such as the pre-S region of hepatitis B virus, the transmembrane protein gp41 of human immunodeficiency virus 1 and the envelope protein gp51 of bovine leukemia virus have been used. The localization of the inserted antigenic determinants on the surface of chimeric capsids does not depend on the presence or absence of the arginine-rich, 39 amino acid-long C terminus of HBcAg.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D001909 Leukemia Virus, Bovine The type species of DELTARETROVIRUS that causes a form of bovine lymphosarcoma (ENZOOTIC BOVINE LEUKOSIS) or persistent lymphocytosis. BLV,Bovine Leukemia Virus,Cattle Leukemia Virus,Leukemia Virus, Cattle,Virus, Bovine Leukemia,Virus, Cattle Leukemia
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D005814 Genes, Viral The functional hereditary units of VIRUSES. Viral Genes,Gene, Viral,Viral Gene
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B

Related Publications

G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
January 2006, Human vaccines,
G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
January 1996, Acta virologica,
G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
January 1998, Advances in virus research,
G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
December 2015, Molecular biotechnology,
G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
October 1990, Molekuliarnaia genetika, mikrobiologiia i virusologiia,
G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
November 1987, The Journal of general virology,
G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
August 1997, The Journal of general virology,
G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
September 2004, The Journal of general virology,
G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
January 1995, Journal of viral hepatitis,
G P Borisova, and I Berzins, and P M Pushko, and P Pumpen, and E J Gren, and V V Tsibinogin, and V Loseva, and V Ose, and R Ulrich, and H Siakkou
January 1992, Archives of virology,
Copied contents to your clipboard!